Literature DB >> 8797699

Adult T-cell leukemia/lymphoma in Jamaica: 1986-1995.

B Hanchard1.   

Abstract

Adult T-cell leukemia/lymphoma (ATL) is the commonest lymphoid malignancy in adult Jamaicans, reflecting the role of the causative agent, human T-cell lymphotrophic virus type I (HTLV-I), in altering the pattern of non-Hodgkin lymphoma in an endemic area. A total of 126 cases of ATL were registered in Jamaica between January 1985 and July 1995. There were 65 male and 61 female patients (male-female ratio, 1:1), with a mean age of 43 years (17-85 years). The majority of cases were acute subtype (46.8%), followed by lymphoma (27%), chronic (20.6%), and smoldering (5.6%) types. The disease is associated with a high mortality, with only five of the 126 patients currently alive. The median survival rate is 20 weeks. The epidemiologic, clinical, and laboratory features are similar to those reported in Japan and Brazil, except that the mean age of patients, identical in Jamaica and Brazil (43 years), is 11 years younger than that in Japan (54 years). Given the theory that ATL develops after a long incubation period after early life exposure to HTLV-I facilitated by mother-to-child transmission via breast milk, and the fact that mothers of ATL patients have a high incidence of HTLV-I seropositivity, it would appear that reduction in the incidence of this disease could be achieved by methods aimed at preventing this mode of transmission.

Entities:  

Mesh:

Year:  1996        PMID: 8797699     DOI: 10.1097/00042560-199600001-00005

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  20 in total

1.  Human T cell leukaemia/lymphoma virus infection in pregnant women in the United Kingdom: population study.

Authors:  A E Ades; S Parker; J Walker; M Edginton; G P Taylor; J N Weber
Journal:  BMJ       Date:  2000-06-03

2.  Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.

Authors:  Yoshimi Enose-Akahata; Anna Abrams; Kory R Johnson; Elizabeth M Maloney; Steven Jacobson
Journal:  Blood       Date:  2012-02-07       Impact factor: 22.113

Review 3.  Transmission of tropical and geographically restricted infections during solid-organ transplantation.

Authors:  P Martín-Dávila; J Fortún; R López-Vélez; F Norman; M Montes de Oca; P Zamarrón; M I González; A Moreno; T Pumarola; G Garrido; A Candela; S Moreno
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 4.  Adult T-cell leukemia/lymphoma and HTLV-1.

Authors:  Renaud Mahieux; Antoine Gessain
Journal:  Curr Hematol Malig Rep       Date:  2007-10       Impact factor: 3.952

Review 5.  Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells.

Authors:  Toshiki Watanabe
Journal:  Blood       Date:  2017-01-23       Impact factor: 22.113

Review 6.  Leukemogenesis of adult T-cell leukemia.

Authors:  Jun-ichirou Yasunaga; Masao Matsuoka
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

7.  Hospital admissions for human T-cell lymphotropic virus type-1 (HTLV-1) associated diseases in Dominica.

Authors:  O Adedayo; G Grell; P Bellot
Journal:  Postgrad Med J       Date:  2003-06       Impact factor: 2.401

Review 8.  Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant?

Authors:  E H Phillips; A Hodson; O Hermine; A Bazarbachi; K Cwynarski
Journal:  Bone Marrow Transplant       Date:  2016-09-12       Impact factor: 5.483

9.  New insights into prevalence, genetic diversity, and proviral load of human T-cell leukemia virus types 1 and 2 in pregnant women in Gabon in equatorial central Africa.

Authors:  Sonia Lekana-Douki Etenna; Mélanie Caron; Guillaume Besson; Maria Makuwa; Antoine Gessain; Antoine Mahé; Mirdad Kazanji
Journal:  J Clin Microbiol       Date:  2008-09-24       Impact factor: 5.948

10.  Rapidly fatal HTLV-1-associated T-cell leukemia/lymphoma in a patient with SLE.

Authors:  Ruth D E Fritsch-Stork; Roos J Leguit; Ronald H W M Derksen
Journal:  Nat Rev Rheumatol       Date:  2009-05       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.